Healthcare

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

NORTH CHICAGO, Ill., June 2, 2026, 04:00 GMT-04

AbbVie-AQUIPTA-EC-App

Read full article →

Ping An Launches "Ping An Home" Service Brand

HONG KONG and SHANGHAI, June 2, 2026, 03:23 GMT-04

PingAn-Home

Read full article →

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

SHANGHAI, June 2, 2026, 00:54 GMT-04

CorrectSequence-VOC

Read full article →

EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

THOUSAND OAKS, Calif., June 1, 2026, 16:00 GMT-04

Amgen-IMDYLLTRA

Read full article →

Hyland Launches Next Wave of AI Platform Innovations to Unlock the Content-Powered Agentic Enterprise

KISSIMMEE, Fla., June 1, 2026, 08:32 GMT-04

Hyland-new-wave-ai

Read full article →

The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight

LAS VEGAS, June 1, 2026, 08:31 GMT-04

DELVEINSIGHT-EGFR

Read full article →

Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration

MISGAV, Israel and GUANGZHOU, China, June 1, 2026, 07:00 GMT-04

BIOND-GIBF

Read full article →

Cellulose Ether & Derivatives Market worth $16.47 billion by 2031- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 1, 2026, 06:59 GMT-04

MARKETSANDMARKETS

Read full article →

Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

BOSTON, June 1, 2026, 06:30 GMT-04

Skyhawk-SKY-0515

Read full article →

LUCENT Appoints Simon Doyle as CEO with Matthew Goodman Taking Chief Medical Officer Position

LONDON, June 1, 2026, 03:00 GMT-04

LUCENT-CEO

Read full article →

MRI Systems Market worth $9.68 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., May 29, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

NORTH CHICAGO, Ill., May 29, 2026, 08:00 GMT-04

AbbVie-VENCLYXTO®

Read full article →

UPMC Italy and United Imaging Healthcare bring Europe's first CE-marked uRT-linac 506c to Italy

STOCKHOLM, May 29, 2026, 03:58 GMT-04

UPMC-Italy

Read full article →

Air Sanitizer Market to Reach USD 2.25 Billion by 2033, Driven by Indoor Air Quality Priorities, Healthcare Adoption, and Advanced Air Treatment Technologies: Verified Market Research

LEWES, Del., May 28, 2026, 11:45 GMT-04

Verified-Market-Resea

Read full article →

Remote Patient Monitoring Market to Reach US$ 117.9 Bn by 2033 Expands Amid Digital Healthcare Transformation - Persistence Market Research

LONDON, May 28, 2026, 10:15 GMT-04

Persistence-Market

Read full article →

Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight

LAS VEGAS, May 28, 2026, 10:01 GMT-04

DELVEINSIGHT

Read full article →

Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable

SHANGHAI, May 28, 2026, 04:21 GMT-04

SHANGHAI

Read full article →

Grady Health System goes live with Sectra Amplifier Services to enable smooth implementation of AI--enhancing diagnostic workflows across sites

LINKÖPING, Sweden, May 28, 2026, 03:45 GMT-04

SECTRA-Grady-Health

Read full article →

Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease

SUZHOU, China and MÖLNDAL, Sweden, May 28, 2026, 22:51 GMT-04

Ribo-Clinical-Trial

Read full article →

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test

SINGAPORE, May 27, 2026, 18:00 GMT-04

GENE-FDA

Read full article →